scholarly journals (S)-5-(2′-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder

2020 ◽  
Vol 3 (3) ◽  
pp. 509-523
Author(s):  
Jessica L. Armstrong ◽  
Austen B. Casey ◽  
Tanishka S. Saraf ◽  
Munmun Mukherjee ◽  
Raymond G. Booth ◽  
...  
eNeuro ◽  
2017 ◽  
Vol 4 (1) ◽  
pp. ENEURO.0380-16.2017 ◽  
Author(s):  
D. Sinclair ◽  
R. Featherstone ◽  
M. Naschek ◽  
J. Nam ◽  
A. Du ◽  
...  

2005 ◽  
Vol 4 (7) ◽  
pp. 420-430 ◽  
Author(s):  
C. M. Spencer ◽  
O. Alekseyenko ◽  
E. Serysheva ◽  
L. A. Yuva-Paylor ◽  
R. Paylor

2021 ◽  
Author(s):  
Sepideh Afshar ◽  
Sevda Lule ◽  
Gengyang Yuan ◽  
Xiying Qu ◽  
Chuzhi Pan ◽  
...  

Author(s):  
Richard Paylor ◽  
Alexia M. Thomas ◽  
Surabi Veeraragavan ◽  
Corinne M. Spencer

Chapter 7 is concerned with the presence of autism spectrum disorder (ASD) in individuals with Fragile X Syndrome (FXS). It is estimated that 21–50% of individuals with FXS meet the criteria for autism or autism with pervasive developmental delay not otherwise specified. Importantly, recent findings indicate that approximately 2–6% of individuals with ASDs have a mutation in the FMR1 gene, making it one of the most significant single genes associated with the presence of ASD.


Sign in / Sign up

Export Citation Format

Share Document